Vitronectin is a multifunctional plasma glycoprotein which mayregulate the systems relatedto protease cascades such as the coagulation, fibrinolysis, andcomplement systems as well as cell adhesion.Solid-phase assays and affinity chromatography on immobilizedglycolipids indicated that vitronectinpurified under denaturing conditions bound to sulfatide(Gal(3-SO
4)
1-1ceramide), cholesterol3-sulfate,and various phospholipids, but not gangliosides. Only the unfoldedor multimeric form of vitronectinbound to sulfatide, suggesting a conformational dependency of thebinding activity, while vitronectinbound to cholesterol 3-sulfate regardless of its conformational state.The recombinant domains of humanvitronectin and mutants with certain domains deleted were separatelyexpressed in
E. coli as fusion proteins.Using the recombinants, sulfatide-, phosphatidylserine-,cholesterol 3-sulfate-, Type I collagen-, heparin-,and
-endorphin-binding activities were found to be attributable tohemopexin domain 2 and hemopexindomain 1. The possibility was suggested that the presence of asomatomedin domain and/or connectingregion flanking hemopexin domain 1 inactivated its heparin binding.De-
N-glycosylation of plasmavitronectin significantly affected the cholesterol sulfate- andcollagen-binding activities, although its effectswere opposite. These findings suggest that diverse ligand-bindingactivities could be attributed to pexinfamily motifs but that the interdomain interactions and glycosylationsmodulate the ligand binding activitiesof vitronectin.